FAS-associated factor 1 (FAF1) Diverse functions and implications for oncogenesis

被引:105
作者
Menges, Craig W. [1 ]
Altomare, Deborah A. [1 ]
Testa, Joseph R. [1 ]
机构
[1] Fox Chase Canc Ctr, Human Genet Program, Philadelphia, PA 19111 USA
关键词
TNF alpha; NF kappa beta; anti-apoptosis; proteasomal degradation; ubiquitination; tumor suppressor gene; mesothelioma; NF-KAPPA-B; PROTEIN-KINASE CK2; MANTLE CELL LYMPHOMA; UBIQUITIN-PROTEASOME PATHWAY; FACTOR-I; INDUCED APOPTOSIS; TRANSCRIPTION FACTOR; PARKINSONS-DISEASE; GASTRIC-CANCER; MESOTHELIOMA;
D O I
10.4161/cc.8.16.9280
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
FAS-associated factor 1, FAF1, is an evolutionarily conserved protein that has several protein interaction domains. Although FAF1 was initially identified as a member of the FAS death-inducing signaling complex, subsequent work has revealed that FAF1 functions in diverse biological processes. FAF1 has been shown to play an important role in normal development and neuronal cell survival, whereas FAF1 downregulation may contribute to multiple aspects of tumorigenesis. In particular, there is compelling evidence implicating FAF1 as a tumor suppressor involved in the regulation of apoptosis and NF kappa B activity, as well as in ubiquitination and proteasomal degradation. Here, we highlight FAF1's role in NF kappa B signaling and postulate that this pathway has critical connotations for the pathogenesis and treatment of human cancers.
引用
收藏
页码:2528 / 2534
页数:7
相关论文
共 54 条
[1]
Synergistic effect of histone deacetylase inhibitors FK228 and m-carboxycinnamic acid bis-hydroxamide with proteasome inhibitors PSI and PS-341 against gastrointestinal adenocarcinoma cells [J].
Adachi, M ;
Zhang, YB ;
Zhao, XD ;
Minami, T ;
Kawamura, R ;
Hinoda, Y ;
Imai, K .
CLINICAL CANCER RESEARCH, 2004, 10 (11) :3853-3862
[2]
Fas-associated factor (FAF1) is required for the early cleavage-stages of mouse embryo [J].
Adham, Ibrahim M. ;
Khulan, Janchiv ;
Held, Torsten ;
Schmidt, Bernhardt ;
Meyer, Barbara I. ;
Meinhardt, Andreas ;
Engel, Wolfgang .
MOLECULAR HUMAN REPRODUCTION, 2008, 14 (04) :207-213
[3]
Activated TNF-α/NF-κB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice [J].
Altomare, Deborah A. ;
Menges, Craig W. ;
Pei, Jianming ;
Zhang, Lili ;
Skele-Stump, Kristine L. ;
Carbone, Michele ;
Kane, Agnes B. ;
Testa, Joseph R. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) :3420-3425
[4]
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls [J].
Baud, Veronique ;
Karin, Michael .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :33-40
[5]
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling [J].
Bea, Silvia ;
Salaverria, Itziar ;
Armengol, Lluis ;
Pinyol, Magda ;
Fernandez, Veronica ;
Hartmann, Elena M. ;
Jares, Pedro ;
Amador, Virginia ;
Hernandez, Luis ;
Navarro, Alba ;
Ott, German ;
Rosenwald, Andreas ;
Estivill, Xavier ;
Campo, Elias .
BLOOD, 2009, 113 (13) :3059-3069
[6]
BESCHE H, 2009, BIOCHEMISTRY
[7]
Fas-associated factor 1 and Parkinson's disease [J].
Betarbet, Ranjita ;
Anderson, Leah R. ;
Gearing, Marla ;
Gearing, Marla ;
Hodges, Tiffany R. ;
Fritz, Jason J. ;
Lah, James J. ;
Levey, Allan I. .
NEUROBIOLOGY OF DISEASE, 2008, 31 (03) :309-315
[8]
Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors [J].
Birle, Diana C. ;
Hedley, David W. .
CANCER RESEARCH, 2007, 67 (04) :1735-1743
[9]
Bjorling-Poulsen M, 2003, INT J ONCOL, V23, P1015
[10]
Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors [J].
Borczuk, A. C. ;
Cappellini, G. C. A. ;
Kim, H. K. ;
Hesdorffer, M. ;
Taub, R. N. ;
Powell, C. A. .
ONCOGENE, 2007, 26 (04) :610-617